These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30992933)

  • 1. The dawn of a new era in the treatment of HCV infection: A view from the USA.
    Pockros PJ
    Clin Liver Dis (Hoboken); 2014 Nov; 4(5):107-108. PubMed ID: 30992933
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiological trends among the population with chronic HCV infection in the Netherlands.
    Maan R; Toes-Zoutendijk E; Veldt BJ; Hansen BE; van der Meer AJ; de Knegt RJ
    Antivir Ther; 2016; 21(3):207-15. PubMed ID: 26436201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New Era.
    Gentile I; Borgia F; Zappulo E; Buonomo AR; Spera AM; Castaldo G; Borgia G
    Rev Recent Clin Trials; 2014; 9(1):1-7. PubMed ID: 23859195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection.
    Butt AA; Fultz SL; Kwoh CK; Kelley D; Skanderson M; Justice AC
    Hepatology; 2004 Jul; 40(1):115-9. PubMed ID: 15239093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous manifestations of hepatitis C in the era of new antiviral agents.
    Garcovich S; Garcovich M; Capizzi R; Gasbarrini A; Zocco MA
    World J Hepatol; 2015 Nov; 7(27):2740-8. PubMed ID: 26644817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy.
    Bowring MG; Kucirka LM; Massie AB; Ishaque T; Bae S; Shaffer AA; Garonzik Wang J; Sulkowski M; Desai N; Segev DL; Durand CM
    Transplantation; 2018 Dec; 102(12):2088-2095. PubMed ID: 29912046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Liver Transpl; 2019 Apr; 25(4):598-609. PubMed ID: 30716208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing frequency and improved outcomes of hepatitis C-related liver transplantation in the era of direct-acting antivirals - a retrospective cohort study.
    Arora SS; Axley P; Ahmed Z; Satapathy SK; Wong R; Kuo YF; Singal AK
    Transpl Int; 2019 Aug; 32(8):854-864. PubMed ID: 30866110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming.
    Ellwanger JH; Kaminski VL; Valverde-Villegas JM; Simon D; Lunge VR; Chies JAB
    Infect Genet Evol; 2018 Dec; 66():376-391. PubMed ID: 28811194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [FIRST GENERATION PROTEASE INHIBITOR BASED TRIPLE THERAPY FOR HCV GENOTYPE 1--LOOKING BACK WHILE PROCEEDING TO A PROMISING ERA].
    Ben Yakov G; Montano D; Abu Freha N; Etzion O; Dizingof V; Mushkalo A; Shwarts D; Monitin S; Takchick A; Zilberman D; Sikuler E; Fich A
    Harefuah; 2016 May; 155(5):272-5, 324, 323. PubMed ID: 27526553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do we really need more evidence to use hepatitis C positive donor kidney more liberally?
    Joglekar K; Eason JD; Molnar MZ
    Clin Kidney J; 2017 Aug; 10(4):560-563. PubMed ID: 28835817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.
    Belli LS; Perricone G; Adam R; Cortesi PA; Strazzabosco M; Facchetti R; Karam V; Salizzoni M; Andujar RL; Fondevila C; De Simone P; Morelli C; Fabregat-Prous J; Samuel D; Agarwaal K; Moreno Gonzales E; Charco R; Zieniewicz K; De Carlis L; Duvoux C;
    J Hepatol; 2018 Oct; 69(4):810-817. PubMed ID: 29940268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated to the career choice of family medicine among Japanese physicians: the dawn of a new era.
    Ie K; Tahara M; Murata A; Komiyama M; Onishi H
    Asia Pac Fam Med; 2014; 13():11. PubMed ID: 28392748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute cellular rejection in hepatitis C recipients following liver transplantation in the era of direct-acting antivirals: chronological analysis of the United Network for Organ Sharing database.
    Tanaka T; Voigt MD
    J Hepatobiliary Pancreat Sci; 2019 Sep; 26(9):393-400. PubMed ID: 31211912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.
    van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action.
    Paeshuyse J; Dallmeier K; Neyts J
    Curr Opin Virol; 2011 Dec; 1(6):590-8. PubMed ID: 22440916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct-acting antiviral therapies in the United States.
    Young K; Liu B; Bhuket T; Gish RG; Wong RJ
    J Viral Hepat; 2019 Mar; 26(3):350-361. PubMed ID: 30412318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in pediatric hepatitis C transplant recipients: analysis of the UNOS database.
    Gupta M; Bahirwani R; Levine MH; Malik S; Goldberg D; Reddy KR; Shaked A
    Pediatr Transplant; 2015 Mar; 19(2):153-63. PubMed ID: 25495572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment.
    Hajarizadeh B; Grebely J; McManus H; Estes C; Razavi H; Gray RT; Alavi M; Amin J; McGregor S; Sievert W; Thompson A; Dore GJ
    J Gastroenterol Hepatol; 2017 Jan; 32(1):229-236. PubMed ID: 27197716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experience.
    Camargo JF; Anjan S; Chin-Beckford N; Morris MI; Abbo LM; Simkins J; Ciancio G; Chen LJ; Burke GW; Figueiro J; Guerra G; Kupin WL; Mattiazzi A; Ortigosa-Goggins M; Ram Bhamidimarri K; Roth D
    Clin Transplant; 2019 May; 33(5):e13532. PubMed ID: 30866102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.